Trials / Unknown
UnknownNCT03712722
Fecal Microbiota Transplantation (FMT) for Clostridium Difficile
Fecal Microbiota Transplantation (FMT) for Recurrent Clostridium Difficile Infection - an Observational Cohort Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Faecal microbiota transplantation (FMT) is used for recurrent Clostridium difficile infection (rCDI) as part of an quality improvement initiative and conducted within the framework of Center for Faecal Microbiota Transplantation at Aarhus University Hospital (CEFTA).
Detailed description
Patients are assessed, treated and monitored at Aarhus University Hospital (AUH) as an Integrated part of the project.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Faecal microbiota transplantation (FMT) | FMT delivered by colonoscopy, nasojejunal tube, glycerol-based capsules, or freeze-dried encapsulated donor faeces |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2023-12-31
- Completion
- 2024-12-31
- First posted
- 2018-10-19
- Last updated
- 2021-05-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03712722. Inclusion in this directory is not an endorsement.